131 – 140 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly
(
- Contribution to journal › Article
-
Mark
A quick test for cognitive speed: a measure of cognitive speed in dementia with lewy bodies.
(
- Contribution to journal › Article
-
Mark
Prediction of Alzheimer's Disease Using the CSF Abeta42/Abeta40 Ratio in Patients with Mild Cognitive Impairment.
(
- Contribution to journal › Article
-
Mark
Soluble adhesion molecules and angiotensin-converting enzyme in dementia.
(
- Contribution to journal › Article
-
Mark
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
(
- Contribution to journal › Article
-
Mark
Patients with Lewy body dementia use more resources than those with Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Patients With Dementia With Lewy Bodies Have More Impaired Quality of Life Than Patients With Alzheimer Disease.
(
- Contribution to journal › Article
-
Mark
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
(
- Contribution to journal › Article
- 2006
-
Mark
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
(
- Contribution to journal › Article
- 2005
-
Mark
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
(
- Contribution to journal › Scientific review